Comparison between Amanta Healthcare IPO and Glottis IPO.
Amanta Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Glottis IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Amanta Healthcare IPO is up to ₹126.00 Cr whereas the issue size of the Glottis IPO is up to ₹307.00 Cr. The final issue price of Amanta Healthcare IPO is ₹126.00 per share and of Glottis IPO is ₹129.00 per share.
| Amanta Healthcare IPO | Glottis IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹120.00 per share | ₹120.00 per share |
| Issue Price (Upper) | ₹126.00 per share | ₹129.00 per share |
| Issue Price (Final) | ₹126.00 per share | ₹129.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 119 shares | 114 shares |
| Fresh Issue Size | 1,00,00,000 shares | 1,24,03,000 shares |
| Fresh Issue Size (Amount) | up to ₹126.00 Cr | up to ₹160.00 Cr |
| OFS Issue Size | 0 shares | 1,13,95,640 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹147.00 Cr |
| Issue Size Total | 1,00,00,000 shares | 2,37,98,640 shares |
| Issue Size Total (Amount) | up to ₹126.00 Cr | up to ₹307.00 Cr |
Amanta Healthcare IPO opens on Sep 01, 2025, while Glottis IPO opens on Sep 29, 2025. The closing date of Amanta Healthcare IPO and Glottis IPO is Sep 03, 2025, and Oct 01, 2025, respectively.
| Amanta Healthcare IPO | Glottis IPO | |
|---|---|---|
| Anchor Bid Date | Aug 29, 2025 | Sep 26, 2025 |
| Issue Open | Sep 01, 2025 | Sep 29, 2025 |
| Issue Close | Sep 03, 2025 | Oct 01, 2025 |
| Basis Of Allotment (Tentative) | Sep 04, 2025 | Oct 03, 2025 |
| Initiation of Refunds (Tentative) | Sep 08, 2025 | Oct 06, 2025 |
| Credit of Share (Tentative) | Sep 08, 2025 | Oct 06, 2025 |
| Listing date (Tentative) | Sep 09, 2025 | Oct 07, 2025 |
| Anchor Lockin End date 1 | Oct 03, 2025 | Nov 01, 2025 |
| Anchor Lockin End date 2 | Dec 02, 2025 | Dec 31, 2025 |
Amanta Healthcare IPO P/E ratio is 34.59, as compared to Glottis IPO P/E ratio of 18.38.
| Amanta Healthcare IPO | Glottis IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Amanta Healthcare Ltd.'s revenue decreased by 2% and profit after tax (PAT) rose by 189% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Glottis Ltd.'s revenue increased by 89% and profit after tax (PAT) rose by 81% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 85.6 | 98.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 63.56 | 74.23 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 34.59 | 18.38 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹489.25 Cr. | ₹1192.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 12.42% | 56.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 13.72% | 72.58% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.02 | 0.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.64 | ₹7.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10.89% | 56.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Amanta Healthcare IPO Retail Individual Investors (RII) are offered 35,00,000 shares while in Glottis IPO retail investors are offered 35,00,000 shares. Qualified Institutional Buyers (QIB) are offered 20,00,000 shares in Amanta Healthcare IPO and 28,55,837 shares in Glottis IPO.
| Amanta Healthcare IPO | Glottis IPO | |
|---|---|---|
| Anchor Investor Reservation | 30,00,000 shares | 42,83,755 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 20,00,000 shares | 28,55,837 shares |
| NII | 15,00,000 shares | 71,39,592 shares |
| RII | 35,00,000 shares | 95,19,456 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 1,00,00,000 shares | 2,37,98,640 shares |
Amanta Healthcare IPO subscribed 82.60x in total, whereas Glottis IPO subscribed 2.12x.
| Amanta Healthcare IPO | Glottis IPO | |
|---|---|---|
| QIB (times) | 35.86x | 1.84x |
| NII (times) | 209.40x | 3.08x |
| Big NII (times) | 226.13x | 3.77x |
| Small NII (times) | 175.96x | 1.71x |
| RII (times) | 54.96x | 1.47x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 82.60x | 2.12x |
